These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20397688)

  • 1. Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.
    Viswanathan S; Kovacs Z; Green KN; Ratnakar SJ; Sherry AD
    Chem Rev; 2010 May; 110(5):2960-3018. PubMed ID: 20397688
    [No Abstract]   [Full Text] [Related]  

  • 2. The developmental history of the gadolinium chelates as intravenous contrast media for magnetic resonance.
    Runge VM; Ai T; Hao D; Hu X
    Invest Radiol; 2011 Dec; 46(12):807-16. PubMed ID: 22094366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
    J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Stability" of gadolinium chelates.
    Tweedle MF
    Br J Radiol; 2007 Jul; 80(955):583-4; author reply 584-5. PubMed ID: 17704319
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI micelles self-assembled from synthetic gadolinium-based nano building blocks.
    Babič A; Vorobiev V; Trefalt G; Crowe LA; Helm L; Vallée JP; Allémann E
    Chem Commun (Camb); 2019 Jan; 55(7):945-948. PubMed ID: 30604781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of molecular descriptors in the design of gadolinium (III) chelates as MRI contrast agents.
    Maiocchi A
    Mini Rev Med Chem; 2003 Dec; 3(8):845-59. PubMed ID: 14529503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
    Gugliotta G; Botta M; Tei L
    Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxivity enhancement of aquated Tris(β-diketonate)gadolinium(III) chelates by confinement within ultrashort single-walled carbon nanotubes.
    Law JJ; Guven A; Wilson LJ
    Contrast Media Mol Imaging; 2014; 9(6):409-12. PubMed ID: 24764189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environment-sensitive and enzyme-sensitive MR contrast agents.
    Querol M; Bogdanov A
    Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
    Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
    Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncovalent functionalization of carbon nanotubes with amphiphilic gd3+ chelates: toward powerful t1 and t2 MRI contrast agents.
    Richard C; Doan BT; Beloeil JC; Bessodes M; Tóth E; Scherman D
    Nano Lett; 2008 Jan; 8(1):232-6. PubMed ID: 18088153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
    Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
    Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
    Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
    Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of linear and macrocyclic gadolinium based contrast agents.
    Schmitt-Willich H
    Br J Radiol; 2007 Jul; 80(955):581-2; author reply 584-5. PubMed ID: 17704318
    [No Abstract]   [Full Text] [Related]  

  • 17. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
    Martinelli J; Fekete M; Tei L; Botta M
    Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
    Martin VV; Ralston WH; Hynes MR; Keana JF
    Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
    J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.